INCY Earnings

Quarterly EPS
$0.55
Q3 2024
$1.04
Q4 2024
$0.82
Q1 2025
$2.09
Q2 2025
$2.17
Q3 2025
$1.52
Q4 2025
$1.52
Q1 2026
$2.92
Q2 2026
Latest Revenue1.7B
Latest Net Income585.6M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$2.921.7B585.6M+37.7%+39.7%
Q1 2026$1.521.3B303.3M+20.9%+85.4%
Q4 2025$1.521.5B299.3M+27.8%+46.2%
Q3 2025$2.171.4B424.2M+20.0%+294.5%
Q2 2025$2.091.2B405.0M+16.5%+202.5%
Q1 2025$0.821.1B158.2M+19.5%+7.9%
Q4 2024$1.041.2B201.2M+16.3%+15.6%
Q3 2024$0.551.1B106.5M+23.8%-27.6%
Q2 2024-$2.041.0B-444601000
Q1 2024$0.76880.9M169.5M
Q4 2023$0.901.0B201.1M
Q3 2023$0.76919.0M171.3M
Incyte Genomics (INCY) — Earnings